{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:33Z","timestamp":1793724273331,"version":"4.6.1"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-025-10306-x","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:09:28Z","timestamp":1765375768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ferroptosis at the intersection of radiotherapy and immunotherapy"],"prefix":"10.1007","volume":"44","author":[{"given":"Gui-Xia","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Shan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"10306_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou, W., Wolchok, J. D., & Chen, L. (2016). PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Science Translational Medicine, 8, Article 328rv324. https:\/\/doi.org\/10.1126\/scitranslmed.aad7118","journal-title":"Science Translational Medicine"},{"key":"10306_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1903827","volume":"18","author":"L Tagliaferri","year":"2022","unstructured":"Tagliaferri, L., et al. (2022). Immunotherapy and radiotherapy in melanoma: A multidisciplinary comprehensive review. Human Vaccines & Immunotherapeutics, 18, Article 1903827. https:\/\/doi.org\/10.1080\/21645515.2021.1903827","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10306_CR3","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1158\/1078-0432.Ccr-19-2034","volume":"26","author":"A Arina","year":"2020","unstructured":"Arina, A., Gutiontov, S. I., & Weichselbaum, R. R. (2020). Radiotherapy and immunotherapy for cancer: From \u201csystemic\u201d to \u201cmultisite.\u201d Clinical Cancer Research\u202f: An Official Journal of the American Association for Cancer Research, 26, 2777\u20132782. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-2034","journal-title":"Clinical Cancer Research : An Official Journal of the American Association for Cancer Research"},{"key":"10306_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","volume":"2","author":"AR Parikh","year":"2021","unstructured":"Parikh, A. R., et al. (2021). Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nature Cancer, 2, 1124\u20131135. https:\/\/doi.org\/10.1038\/s43018-021-00269-7","journal-title":"Nature Cancer"},{"key":"10306_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.eururo.2021.12.006","volume":"81","author":"S Siva","year":"2022","unstructured":"Siva, S., et al. (2022). Stereotactic radiotherapy and short-course pembrolizumab for oligometastatic renal cell carcinoma-The RAPPORT trial. European Urology, 81, 364\u2013372. https:\/\/doi.org\/10.1016\/j.eururo.2021.12.006","journal-title":"European Urology"},{"key":"10306_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.Cd-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang, X., et al. (2019). Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discovery, 9, 1673\u20131685. https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-0338","journal-title":"Cancer Discovery"},{"key":"10306_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021). Broadening horizons: The role of ferroptosis in cancer. Nature reviews. Clinical oncology, 18, 280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0","journal-title":"Nature reviews. Clinical oncology"},{"key":"10306_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.948389","volume":"12","author":"K Cheng","year":"2022","unstructured":"Cheng, K., et al. (2022). Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field. Frontiers in Oncology, 12, Article 948389. https:\/\/doi.org\/10.3389\/fonc.2022.948389","journal-title":"Frontiers in Oncology"},{"key":"10306_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J., et al. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149, 1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"10306_CR10","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang, D., Minikes, A. M., & Jiang, X. (2022). Ferroptosis at the intersection of lipid metabolism and cellular signaling. Molecular Cell, 82, 2215\u20132227. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.022","journal-title":"Molecular Cell"},{"key":"10306_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu, H., Guo, P., Xie, X., Wang, Y., & Chen, G. (2017). Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. Journal of Cellular and Molecular Medicine, 21, 648\u2013657. https:\/\/doi.org\/10.1111\/jcmm.13008","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10306_CR12","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao, J. Y., & Dixon, S. J. (2016). Mechanisms of ferroptosis. Cellular and Molecular Life Sciences\u202f: CMLS, 73, 2195\u20132209. https:\/\/doi.org\/10.1007\/s00018-016-2194-1","journal-title":"Cellular and Molecular Life Sciences : CMLS"},{"key":"10306_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L., et al. (2018). Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death and Differentiation, 25, 486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4","journal-title":"Cell Death and Differentiation"},{"key":"10306_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng, X., et al. (2023). Ferroptosis: A novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Experimental Hematology & Oncology, 12, 65. https:\/\/doi.org\/10.1186\/s40164-023-00427-w","journal-title":"Experimental Hematology & Oncology"},{"key":"10306_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R., et al. (2017). Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 171, 273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"10306_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang, W. S., & Stockwell, B. R. (2008). Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chemistry & Biology, 15, 234\u2013245. https:\/\/doi.org\/10.1016\/j.chembiol.2008.02.010","journal-title":"Chemistry & Biology"},{"key":"10306_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","volume":"12","author":"G Lei","year":"2021","unstructured":"Lei, G., Mao, C., Yan, Y., Zhuang, L., & Gan, B. (2021). Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein & Cell, 12, 836\u2013857. https:\/\/doi.org\/10.1007\/s13238-021-00841-y","journal-title":"Protein & Cell"},{"key":"10306_CR18","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang, W. S., et al. (2016). Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proceedings of the National Academy of Sciences of the United States of America, 113, E4966-4975. https:\/\/doi.org\/10.1073\/pnas.1603244113","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10306_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S., et al. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology, 13, 91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nature Chemical Biology"},{"key":"10306_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan, V. E., et al. (2017). Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nature Chemical Biology, 13, 81\u201390. https:\/\/doi.org\/10.1038\/nchembio.2238","journal-title":"Nature Chemical Biology"},{"key":"10306_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong, L., et al. (2019). Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell chemical biology, 26, 420-432.e429. https:\/\/doi.org\/10.1016\/j.chembiol.2018.11.016","journal-title":"Cell chemical biology"},{"key":"10306_CR22","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. (2022). Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell, 185, 2401\u20132421. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003","journal-title":"Cell"},{"key":"10306_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah, R., Shchepinov, M. S., & Pratt, D. A. (2018). Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Central Science, 4, 387\u2013396. https:\/\/doi.org\/10.1021\/acscentsci.7b00589","journal-title":"ACS Central Science"},{"key":"10306_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon, S. J., et al. (2014). Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife, 3, Article e02523. https:\/\/doi.org\/10.7554\/eLife.02523","journal-title":"eLife"},{"key":"10306_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P., et al. (2014). Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nature Cell Biology, 16, 1180\u20131191. https:\/\/doi.org\/10.1038\/ncb3064","journal-title":"Nature Cell Biology"},{"key":"10306_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018). Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Communications, 38, Article 12. https:\/\/doi.org\/10.1186\/s40880-018-0288-x","journal-title":"Cancer Communications"},{"key":"10306_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","volume":"42","author":"M Conrad","year":"2012","unstructured":"Conrad, M., & Sato, H. (2012). The oxidative stress-inducible cystine\/glutamate antiporter, system x (c) (-): Cystine supplier and beyond. Amino Acids, 42, 231\u2013246. https:\/\/doi.org\/10.1007\/s00726-011-0867-5","journal-title":"Amino Acids"},{"key":"10306_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"BR Stockwell","year":"2020","unstructured":"Stockwell, B. R., Jiang, X., & Gu, W. (2020). Emerging mechanisms and disease relevance of ferroptosis. Trends in Cell Biology, 30, 478\u2013490. https:\/\/doi.org\/10.1016\/j.tcb.2020.02.009","journal-title":"Trends in Cell Biology"},{"key":"10306_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang, F., et al. (2023). Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell metabolism, 35, 84-100.e108. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.021","journal-title":"Cell metabolism"},{"key":"10306_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","volume":"68","author":"D Chen","year":"2017","unstructured":"Chen, D., et al. (2017). NRF2 is a major target of ARF in p53-independent tumor suppression. Molecular cell, 68, 224-232.e224. https:\/\/doi.org\/10.1016\/j.molcel.2017.09.009","journal-title":"Molecular cell"},{"key":"10306_CR31","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., et al. (2018). BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nature Cell Biology, 20, 1181\u20131192. https:\/\/doi.org\/10.1038\/s41556-018-0178-0","journal-title":"Nature Cell Biology"},{"key":"10306_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","volume":"20","author":"A Hafner","year":"2019","unstructured":"Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019). The multiple mechanisms that regulate p53 activity and cell fate. Nature reviews. Molecular cell biology, 20, 199\u2013210. https:\/\/doi.org\/10.1038\/s41580-019-0110-x","journal-title":"Nature reviews. Molecular cell biology"},{"key":"10306_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang, L., et al. (2015). Ferroptosis as a p53-mediated activity during tumour suppression. Nature, 520, 57\u201362. https:\/\/doi.org\/10.1038\/nature14344","journal-title":"Nature"},{"key":"10306_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.951116","volume":"10","author":"J Su","year":"2022","unstructured":"Su, J., et al. (2022). Cooperation effects of radiation and ferroptosis on tumor suppression and radiation injury. Frontiers in Cell and Developmental Biology, 10, Article 951116. https:\/\/doi.org\/10.3389\/fcell.2022.951116","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10306_CR35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao, C., et al. (2021). DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature, 593, 586\u2013590. https:\/\/doi.org\/10.1038\/s41586-021-03539-7","journal-title":"Nature"},{"key":"10306_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.810327","volume":"10","author":"Q Hu","year":"2022","unstructured":"Hu, Q., et al. (2022). Blockade of GCH1\/BH4 axis activates ferritinophagy to mitigate the resistance of colorectal cancer to erastin-induced ferroptosis. Frontiers in Cell and Developmental Biology, 10, Article 810327. https:\/\/doi.org\/10.3389\/fcell.2022.810327","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10306_CR37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K., et al. (2019). The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 575, 688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"key":"10306_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S., et al. (2019). FSP1 is a glutathione-independent ferroptosis suppressor. Nature, 575, 693\u2013698. https:\/\/doi.org\/10.1038\/s41586-019-1707-0","journal-title":"Nature"},{"key":"10306_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","volume":"8","author":"T Ma","year":"2022","unstructured":"Ma, T., et al. (2022). GPX4-independent ferroptosis-A new strategy in disease\u2019s therapy. Cell Death Discovery, 8, 434. https:\/\/doi.org\/10.1038\/s41420-022-01212-0","journal-title":"Cell Death Discovery"},{"key":"10306_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2018.09.008","volume":"133","author":"DA Stoyanovsky","year":"2019","unstructured":"Stoyanovsky, D. A., et al. (2019). Iron catalysis of lipid peroxidation in ferroptosis: Regulated enzymatic or random free radical reaction? Free Radical Biology & Medicine, 133, 153\u2013161. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.008","journal-title":"Free Radical Biology & Medicine"},{"key":"10306_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101744","volume":"38","author":"TS Anthonymuthu","year":"2021","unstructured":"Anthonymuthu, T. S., et al. (2021). Resolving the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX\/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosis. Redox Biology, 38, Article 101744. https:\/\/doi.org\/10.1016\/j.redox.2020.101744","journal-title":"Redox Biology"},{"key":"10306_CR42","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","volume":"83","author":"W Zhang","year":"2023","unstructured":"Zhang, W., et al. (2023). SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Molecular cell, 83, 4352-4369.e4358. https:\/\/doi.org\/10.1016\/j.molcel.2023.10.042","journal-title":"Molecular cell"},{"key":"10306_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118135","volume":"258","author":"Q Yang","year":"2020","unstructured":"Yang, Q., Liu, W., Zhang, S., & Liu, S. (2020). The cardinal roles of ferroportin and its partners in controlling cellular iron in and out. Life Sciences, 258, Article 118135. https:\/\/doi.org\/10.1016\/j.lfs.2020.118135","journal-title":"Life Sciences"},{"key":"10306_CR44","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","volume":"30","author":"H Feng","year":"2020","unstructured":"Feng, H., et al. (2020). Transferrin receptor is a specific ferroptosis marker. Cell reports, 30, 3411-3423.e3417. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.049","journal-title":"Cell reports"},{"key":"10306_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s42003-021-02060-x","volume":"4","author":"W Guan","year":"2021","unstructured":"Guan, W., et al. (2021). Iron induces two distinct Ca(2+) signalling cascades in astrocytes. Communications Biology, 4, 525. https:\/\/doi.org\/10.1038\/s42003-021-02060-x","journal-title":"Communications Biology"},{"key":"10306_CR46","doi-asserted-by":"publisher","first-page":"11306","DOI":"10.1021\/ja1043177","volume":"132","author":"J Wang","year":"2010","unstructured":"Wang, J., Tian, S., Petros, R. A., Napier, M. E., & Desimone, J. M. (2010). The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. Journal of the American Chemical Society, 132, 11306\u201311313. https:\/\/doi.org\/10.1021\/ja1043177","journal-title":"Journal of the American Chemical Society"},{"key":"10306_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008396","volume":"15","author":"S Mumbauer","year":"2019","unstructured":"Mumbauer, S., Pascual, J., Kolotuev, I., & Hamaratoglu, F. (2019). Ferritin heavy chain protects the developing wing from reactive oxygen species and ferroptosis. PLoS Genetics, 15, Article e1008396. https:\/\/doi.org\/10.1371\/journal.pgen.1008396","journal-title":"PLoS Genetics"},{"key":"10306_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen, X., Yu, C., Kang, R., & Tang, D. (2020). Iron metabolism in ferroptosis. Frontiers in Cell and Developmental Biology, 8, Article 590226. https:\/\/doi.org\/10.3389\/fcell.2020.590226","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10306_CR49","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1038\/s41467-018-06817-7","volume":"9","author":"W Oosterheert","year":"2018","unstructured":"Oosterheert, W., et al. (2018). Cryo-EM structures of human STEAP4 reveal mechanism of iron(III) reduction. Nature Communications, 9, 4337. https:\/\/doi.org\/10.1038\/s41467-018-06817-7","journal-title":"Nature Communications"},{"key":"10306_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","volume":"1173","author":"G Gao","year":"2019","unstructured":"Gao, G., Li, J., Zhang, Y., & Chang, Y. Z. (2019). Cellular iron metabolism and regulation. Advances in Experimental Medicine and Biology, 1173, 21\u201332. https:\/\/doi.org\/10.1007\/978-981-13-9589-5_2","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10306_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/bloodadvances.2016003772","volume":"1","author":"S Khalil","year":"2017","unstructured":"Khalil, S., et al. (2017). A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2. Blood Advances, 1, 1181\u20131194. https:\/\/doi.org\/10.1182\/bloodadvances.2016003772","journal-title":"Blood Advances"},{"key":"10306_CR52","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbrc.2020.07.032","volume":"531","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Liu, Y., Liu, J., Kang, R., & Tang, D. (2020). NEDD4L-mediated LTF protein degradation limits ferroptosis. Biochemical and Biophysical Research Communications, 531, 581\u2013587. https:\/\/doi.org\/10.1016\/j.bbrc.2020.07.032","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10306_CR53","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao, M., et al. (2016). Ferroptosis is an autophagic cell death process. Cell Research, 26, 1021\u20131032. https:\/\/doi.org\/10.1038\/cr.2016.95","journal-title":"Cell Research"},{"key":"10306_CR54","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.devcel.2019.10.007","volume":"51","author":"CW Brown","year":"2019","unstructured":"Brown, C. W., et al. (2019). Prominin2 drives ferroptosis resistance by stimulating iron export. Developmental cell, 51, 575-586.e574. https:\/\/doi.org\/10.1016\/j.devcel.2019.10.007","journal-title":"Developmental cell"},{"key":"10306_CR55","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","volume":"14","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z., et al. (2018). Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells. Autophagy, 14, 2083\u20132103. https:\/\/doi.org\/10.1080\/15548627.2018.1503146","journal-title":"Autophagy"},{"key":"10306_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala, A., Mu\u00f1oz, M. F., & Arg\u00fcelles, S. (2014). Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity, 2014, Article 360438. https:\/\/doi.org\/10.1155\/2014\/360438","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10306_CR57","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1039\/c7mt00177k","volume":"9","author":"C Volani","year":"2017","unstructured":"Volani, C., et al. (2017). Dietary iron loading negatively affects liver mitochondrial function. Metallomics, 9, 1634\u20131644. https:\/\/doi.org\/10.1039\/c7mt00177k","journal-title":"Metallomics"},{"key":"10306_CR58","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu, J., Kang, R., & Tang, D. (2022). Signaling pathways and defense mechanisms of ferroptosis. FEBS Journal, 289, 7038\u20137050. https:\/\/doi.org\/10.1111\/febs.16059","journal-title":"FEBS Journal"},{"key":"10306_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13158","volume":"55","author":"S Yuan","year":"2022","unstructured":"Yuan, S., et al. (2022). Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway. Cell Proliferation, 55, Article e13158. https:\/\/doi.org\/10.1111\/cpr.13158","journal-title":"Cell Proliferation"},{"key":"10306_CR60","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","volume":"15","author":"PW Gout","year":"2001","unstructured":"Gout, P. W., Buckley, A. R., Simms, C. R., & Bruchovsky, N. (2001). Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: A new action for an old drug. Leukemia, 15, 1633\u20131640. https:\/\/doi.org\/10.1038\/sj.leu.2402238","journal-title":"Leukemia"},{"key":"10306_CR61","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., et al. (2019). Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chemical Biology, 26, 623-633.e629. https:\/\/doi.org\/10.1016\/j.chembiol.2019.01.008","journal-title":"Cell Chemical Biology"},{"key":"10306_CR62","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nm.4232","volume":"23","author":"SL Cramer","year":"2017","unstructured":"Cramer, S. L., et al. (2017). Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nature Medicine, 23, 120\u2013127. https:\/\/doi.org\/10.1038\/nm.4232","journal-title":"Nature Medicine"},{"key":"10306_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022). Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduction and Targeted Therapy, 7, 196. https:\/\/doi.org\/10.1038\/s41392-022-01046-3","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10306_CR64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei, G., et al. (2020). The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Research, 30, 146\u2013162. https:\/\/doi.org\/10.1038\/s41422-019-0263-3","journal-title":"Cell Research"},{"key":"10306_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102677","volume":"62","author":"S Liu","year":"2023","unstructured":"Liu, S., et al. (2023). Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis. Redox Biology, 62, Article 102677. https:\/\/doi.org\/10.1016\/j.redox.2023.102677","journal-title":"Redox Biology"},{"key":"10306_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.14218\/jcth.2022.00255","volume":"11","author":"Z Huang","year":"2023","unstructured":"Huang, Z., Xia, H., Cui, Y., Yam, J. W. P., & Xu, Y. (2023). Ferroptosis: From basic research to clinical therapeutics in hepatocellular carcinoma. Journal of Clinical and Translational Hepatology, 11, 207\u2013218. https:\/\/doi.org\/10.14218\/jcth.2022.00255","journal-title":"Journal of Clinical and Translational Hepatology"},{"key":"10306_CR67","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta, R., et al. (2014). Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. Journal of the American Chemical Society, 136, 4551\u20134556. https:\/\/doi.org\/10.1021\/ja411006a","journal-title":"Journal of the American Chemical Society"},{"key":"10306_CR68","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","volume":"109","author":"Z Kong","year":"2019","unstructured":"Kong, Z., Liu, R., & Cheng, Y. (2019). Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 109, 2043\u20132053. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.030","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10306_CR69","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/02601060211018360","volume":"28","author":"A Samy","year":"2022","unstructured":"Samy, A., Shah, D., Shahagadkar, P., Shah, H., & Munirathinam, G. (2022). Can diallyl trisulfide, a dietary garlic-derived compound, activate ferroptosis to overcome therapy resistance in prostate cancer? Nutrition and Health, 28, 207\u2013212. https:\/\/doi.org\/10.1177\/02601060211018360","journal-title":"Nutrition and Health"},{"key":"10306_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105305","volume":"164","author":"X Zhou","year":"2021","unstructured":"Zhou, X., et al. (2021). Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacological Research, 164, Article 105305. https:\/\/doi.org\/10.1016\/j.phrs.2020.105305","journal-title":"Pharmacological Research"},{"key":"10306_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3469840","volume":"2020","author":"R Li","year":"2020","unstructured":"Li, R., et al. (2020). Transcriptome investigation and in vitro verification of curcumin-induced HO-1 as a feature of ferroptosis in breast cancer cells. Oxidative Medicine and Cellular Longevity, 2020, Article 3469840. https:\/\/doi.org\/10.1155\/2020\/3469840","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10306_CR72","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","volume":"11","author":"JL Roh","year":"2017","unstructured":"Roh, J. L., Kim, E. H., Jang, H., & Shin, D. (2017). Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biology, 11, 254\u2013262. https:\/\/doi.org\/10.1016\/j.redox.2016.12.010","journal-title":"Redox Biology"},{"key":"10306_CR73","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.7150\/thno.52028","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z., et al. (2021). Holo-lactoferrin: The link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics, 11, 3167\u20133182. https:\/\/doi.org\/10.7150\/thno.52028","journal-title":"Theranostics"},{"key":"10306_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413335","author":"J Zou","year":"2021","unstructured":"Zou, J., et al. (2021). Ferroptosis in non-small cell lung cancer: Progression and therapeutic potential on it. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms222413335","journal-title":"International Journal of Molecular Sciences"},{"key":"10306_CR75","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2021.06.051","volume":"567","author":"J Ni","year":"2021","unstructured":"Ni, J., Chen, K., Zhang, J., & Zhang, X. (2021). Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells. Biochemical and Biophysical Research Communications, 567, 154\u2013160. https:\/\/doi.org\/10.1016\/j.bbrc.2021.06.051","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10306_CR76","doi-asserted-by":"publisher","first-page":"e2101368","DOI":"10.1002\/smll.202101368","volume":"17","author":"LL Zhou","year":"2021","unstructured":"Zhou, L. L., et al. (2021). A ferrocene-functionalized covalent organic framework for enhancing chemodynamic therapy via redox dyshomeostasis. Small (Weinheim an der Bergstrasse, Germany), 17, e2101368. https:\/\/doi.org\/10.1002\/smll.202101368","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10306_CR77","doi-asserted-by":"publisher","first-page":"9865","DOI":"10.7150\/thno.46771","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang, H., et al. (2020). Targeted manganese doped silica nano GSH-cleaner for treatment of liver cancer by destroying the intracellular redox homeostasis. Theranostics, 10, 9865\u20139887. https:\/\/doi.org\/10.7150\/thno.46771","journal-title":"Theranostics"},{"key":"10306_CR78","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1111\/cas.14181","volume":"110","author":"M Yu","year":"2019","unstructured":"Yu, M., et al. (2019). Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Science, 110, 3173\u20133182. https:\/\/doi.org\/10.1111\/cas.14181","journal-title":"Cancer Science"},{"key":"10306_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","volume":"27","author":"GQ Chen","year":"2020","unstructured":"Chen, G. Q., et al. (2020). Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death and Differentiation, 27, 242\u2013254. https:\/\/doi.org\/10.1038\/s41418-019-0352-3","journal-title":"Cell Death and Differentiation"},{"key":"10306_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182921","volume":"12","author":"S Ma","year":"2017","unstructured":"Ma, S., et al. (2017). Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells. PLoS ONE, 12, Article e0182921. https:\/\/doi.org\/10.1371\/journal.pone.0182921","journal-title":"PLoS ONE"},{"key":"10306_CR81","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao, L., et al. (2022). Ferroptosis in cancer and cancer immunotherapy. Cancer Communications, 42, 88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250","journal-title":"Cancer Communications"},{"key":"10306_CR82","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo, J., et al. (2018). Ferroptosis: A novel anti-tumor action for Cisplatin. Cancer Research and Treatment, 50, 445\u2013460. https:\/\/doi.org\/10.4143\/crt.2016.572","journal-title":"Cancer Research and Treatment"},{"key":"10306_CR83","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004381","author":"W Guo","year":"2022","unstructured":"Guo, W., et al. (2022). Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. Journal for Immunotherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-004381","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10306_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2023.100829","volume":"18","author":"H Wang","year":"2023","unstructured":"Wang, H., Qiao, C., Guan, Q., Wei, M., & Li, Z. (2023). Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: Novel insights and perspectives. Asian Journal of Pharmaceutical Sciences, 18, Article 100829. https:\/\/doi.org\/10.1016\/j.ajps.2023.100829","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10306_CR85","doi-asserted-by":"publisher","first-page":"e2001704","DOI":"10.1002\/smll.202001704","volume":"16","author":"Q Jiang","year":"2020","unstructured":"Jiang, Q., et al. (2020). Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy. Small (Weinheim an der Bergstrasse, Germany), 16, e2001704. https:\/\/doi.org\/10.1002\/smll.202001704","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10306_CR86","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1021\/acs.bioconjchem.6b00562","volume":"28","author":"L Yue","year":"2017","unstructured":"Yue, L., et al. (2017). pH-responsive, self-sacrificial nanotheranostic agent for potential In vivo and In vitro dual modal MRI\/CT imaging, real-time, and in situ monitoring of cancer therapy. Bioconjugate Chemistry, 28, 400\u2013409. https:\/\/doi.org\/10.1021\/acs.bioconjchem.6b00562","journal-title":"Bioconjugate Chemistry"},{"key":"10306_CR87","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.7150\/thno.57803","volume":"11","author":"CH Hsieh","year":"2021","unstructured":"Hsieh, C. H., et al. (2021). An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics, 11, 7072\u20137091. https:\/\/doi.org\/10.7150\/thno.57803","journal-title":"Theranostics"},{"key":"10306_CR88","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1021\/acsnano.9b09426","volume":"14","author":"T Xu","year":"2020","unstructured":"Xu, T., et al. (2020). Enhanced ferroptosis by oxygen-boosted phototherapy based on a 2-in-1 nanoplatform of ferrous hemoglobin for tumor synergistic therapy. ACS Nano, 14, 3414\u20133425. https:\/\/doi.org\/10.1021\/acsnano.9b09426","journal-title":"ACS Nano"},{"key":"10306_CR89","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1039\/d0tb00411a","volume":"8","author":"X Yao","year":"2020","unstructured":"Yao, X., et al. (2020). A novel multifunctional FePt\/BP nanoplatform for synergistic photothermal\/photodynamic\/chemodynamic cancer therapies and photothermally-enhanced immunotherapy. Journal of Materials Chemistry B, 8, 8010\u20138021. https:\/\/doi.org\/10.1039\/d0tb00411a","journal-title":"Journal of Materials Chemistry B"},{"key":"10306_CR90","doi-asserted-by":"publisher","first-page":"19912","DOI":"10.1039\/c9nr05684j","volume":"11","author":"D Zhang","year":"2019","unstructured":"Zhang, D., et al. (2019). Tumor microenvironment responsive FePt\/MoS(2) nanocomposites with chemotherapy and photothermal therapy for enhancing cancer immunotherapy. Nanoscale, 11, 19912\u201319922. https:\/\/doi.org\/10.1039\/c9nr05684j","journal-title":"Nanoscale"},{"key":"10306_CR91","doi-asserted-by":"publisher","first-page":"11021","DOI":"10.1039\/d0tb01981j","volume":"8","author":"Y Meng","year":"2020","unstructured":"Meng, Y., et al. (2020). Core-shell FePt-cube@covalent organic polymer nanocomposites: A multifunctional nanocatalytic agent for primary and metastatic tumor treatment. Journal of Materials Chemistry. B, 8, 11021\u201311032. https:\/\/doi.org\/10.1039\/d0tb01981j","journal-title":"Journal of Materials Chemistry. B"},{"key":"10306_CR92","doi-asserted-by":"publisher","first-page":"38395","DOI":"10.1021\/acsami.9b11353","volume":"11","author":"B Yang","year":"2019","unstructured":"Yang, B., et al. (2019). FePt@MnO-based nanotheranostic platform with acidity-triggered dual-ions release for enhanced MR imaging-guided ferroptosis chemodynamic therapy. ACS Applied Materials & Interfaces, 11, 38395\u201338404. https:\/\/doi.org\/10.1021\/acsami.9b11353","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10306_CR93","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1039\/d0tb00708k","volume":"8","author":"Z Hu","year":"2020","unstructured":"Hu, Z., Wang, S., Dai, Z., Zhang, H., & Zheng, X. (2020). A novel theranostic nano-platform (PB@FePt-HA-g-PEG) for tumor chemodynamic-photothermal co-therapy and triple-modal imaging (MR\/CT\/PI) diagnosis. Journal of Materials Chemistry. B, 8, 5351\u20135360. https:\/\/doi.org\/10.1039\/d0tb00708k","journal-title":"Journal of Materials Chemistry. B"},{"key":"10306_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119486","volume":"223","author":"M Gao","year":"2019","unstructured":"Gao, M., et al. (2019). Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy. Biomaterials, 223, Article 119486. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119486","journal-title":"Biomaterials"},{"key":"10306_CR95","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1021\/acsbiomaterials.2c00236","volume":"8","author":"Z Yan","year":"2022","unstructured":"Yan, Z., Wu, S., Zhou, Y., & Li, F. (2022). Acid-responsive micelles releasing cinnamaldehyde enhance RSL3-induced ferroptosis in tumor cells. ACS Biomaterials Science & Engineering, 8, 2508\u20132517. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00236","journal-title":"ACS Biomaterials Science & Engineering"},{"key":"10306_CR96","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/1061186x.2021.1953511","volume":"30","author":"W Li","year":"2022","unstructured":"Li, W., et al. (2022). Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis. Journal of Drug Targeting, 30, 208\u2013218. https:\/\/doi.org\/10.1080\/1061186x.2021.1953511","journal-title":"Journal of Drug Targeting"},{"key":"10306_CR97","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12951-021-00952-y","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang, X., et al. (2021). Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy. Journal of Nanobiotechnology, 19, 204. https:\/\/doi.org\/10.1186\/s12951-021-00952-y","journal-title":"Journal of Nanobiotechnology"},{"key":"10306_CR98","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jconrel.2022.04.002","volume":"345","author":"HT Tran","year":"2022","unstructured":"Tran, H. T., Vong, L. B., Nishikawa, Y., & Nagasaki, Y. (2022). Sorafenib-loaded silica-containing redox nanoparticles for oral anti-liver fibrosis therapy. Journal of Controlled Release, 345, 880\u2013891. https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.002","journal-title":"Journal of Controlled Release"},{"key":"10306_CR99","doi-asserted-by":"publisher","first-page":"30031","DOI":"10.1021\/acsami.0c03564","volume":"12","author":"L Kou","year":"2020","unstructured":"Kou, L., et al. (2020). Tumor microenvironment-responsive, multistaged liposome induces apoptosis and ferroptosis by amplifying oxidative stress for enhanced cancer therapy. ACS Applied Materials & Interfaces, 12, 30031\u201330043. https:\/\/doi.org\/10.1021\/acsami.0c03564","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10306_CR100","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.7150\/thno.32867","volume":"9","author":"T Zhu","year":"2019","unstructured":"Zhu, T., et al. (2019). Ferroptosis promotes photodynamic therapy: Supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment. Theranostics, 9, 3293\u20133307. https:\/\/doi.org\/10.7150\/thno.32867","journal-title":"Theranostics"},{"key":"10306_CR101","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1039\/c9bm00653b","volume":"7","author":"Y Li","year":"2019","unstructured":"Li, Y., et al. (2019). Nanoparticle ferritin-bound erastin and rapamycin: A nanodrug combining autophagy and ferroptosis for anticancer therapy. Biomaterials Science, 7, 3779\u20133787. https:\/\/doi.org\/10.1039\/c9bm00653b","journal-title":"Biomaterials Science"},{"key":"10306_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y., Liu, J., Chen, Y., Weichselbaum, R. R., & Lin, W. (2024). Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Advanced Science, 11, Article e2310309. https:\/\/doi.org\/10.1002\/advs.202310309","journal-title":"Advanced Science"},{"key":"10306_CR103","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bioactmat.2024.02.007","volume":"36","author":"YJ Liu","year":"2024","unstructured":"Liu, Y. J., et al. (2024). A multifunctional biomimetic nanoplatform for image-guideded photothermal-ferroptotic synergistic osteosarcoma therapy. Bioactive Materials, 36, 157\u2013167. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.02.007","journal-title":"Bioactive Materials"},{"key":"10306_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101132","volume":"27","author":"A Huang","year":"2024","unstructured":"Huang, A., et al. (2024). An iron-containing nanomedicine for inducing deep tumor penetration and synergistic ferroptosis in enhanced pancreatic cancer therapy. Materials Today. Bio, 27, Article 101132. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101132","journal-title":"Materials Today. Bio"},{"key":"10306_CR105","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12951-024-02531-3","volume":"22","author":"X Chen","year":"2024","unstructured":"Chen, X., et al. (2024). Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma. Journal of Nanobiotechnology, 22, 264. https:\/\/doi.org\/10.1186\/s12951-024-02531-3","journal-title":"Journal of Nanobiotechnology"},{"key":"10306_CR106","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1021\/acsnano.1c09794","volume":"16","author":"D Liu","year":"2022","unstructured":"Liu, D., et al. (2022). Nano-codelivery of temozolomide and siPD-L1 to reprogram the drug-resistant and immunosuppressive microenvironment in orthotopic glioblastoma. ACS Nano, 16, 7409\u20137427. https:\/\/doi.org\/10.1021\/acsnano.1c09794","journal-title":"ACS Nano"},{"key":"10306_CR107","doi-asserted-by":"publisher","first-page":"26722","DOI":"10.1021\/acsami.9b09784","volume":"11","author":"L Kou","year":"2019","unstructured":"Kou, L., et al. (2019). Ambidextrous approach to disrupt redox balance in tumor cells with increased ROS production and decreased GSH synthesis for cancer therapy. ACS Applied Materials & Interfaces, 11, 26722\u201326730. https:\/\/doi.org\/10.1021\/acsami.9b09784","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10306_CR108","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s11671-021-03497-z","volume":"16","author":"Z Li","year":"2021","unstructured":"Li, Z., et al. (2021). Fe(II) and tannic acid-cloaked MOF as carrier of artemisinin for supply of ferrous ions to enhance treatment of triple-negative breast cancer. Nanoscale Research Letters, 16, 37. https:\/\/doi.org\/10.1186\/s11671-021-03497-z","journal-title":"Nanoscale Research Letters"},{"key":"10306_CR109","doi-asserted-by":"publisher","first-page":"42988","DOI":"10.1021\/acsami.9b16124","volume":"11","author":"P An","year":"2019","unstructured":"An, P., et al. (2019). Photothermal-enhanced inactivation of glutathione peroxidase for ferroptosis sensitized by an autophagy promotor. ACS Applied Materials & Interfaces, 11, 42988\u201342997. https:\/\/doi.org\/10.1021\/acsami.9b16124","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10306_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma, S., Henson, E. S., Chen, Y., & Gibson, S. B. (2016). Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death & Disease, 7, Article e2307. https:\/\/doi.org\/10.1038\/cddis.2016.208","journal-title":"Cell Death & Disease"},{"key":"10306_CR111","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3892\/ijo.2018.4259","volume":"52","author":"Y Yamaguchi","year":"2018","unstructured":"Yamaguchi, Y., Kasukabe, T., & Kumakura, S. (2018). Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis. International Journal of Oncology, 52, 1011\u20131022. https:\/\/doi.org\/10.3892\/ijo.2018.4259","journal-title":"International Journal of Oncology"},{"key":"10306_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171137","volume":"12","author":"MS Hung","year":"2017","unstructured":"Hung, M. S., et al. (2017). Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study. PLoS ONE, 12, Article e0171137. https:\/\/doi.org\/10.1371\/journal.pone.0171137","journal-title":"PLoS ONE"},{"key":"10306_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/srep43598","volume":"7","author":"I Venkata Narayanan","year":"2017","unstructured":"Venkata Narayanan, I., et al. (2017). Transcriptional and post-transcriptional regulation of the ionizing radiation response by ATM and p53. Scientific Reports, 7, Article 43598. https:\/\/doi.org\/10.1038\/srep43598","journal-title":"Scientific Reports"},{"key":"10306_CR114","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1158\/1078-0432.Ccr-12-0298","volume":"19","author":"KE Baidoo","year":"2013","unstructured":"Baidoo, K. E., Yong, K., & Brechbiel, M. W. (2013). Molecular pathways: Targeted \u03b1-particle radiation therapy. Clinical Cancer Research, 19, 530\u2013537. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-0298","journal-title":"Clinical Cancer Research"},{"key":"10306_CR115","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2018.01.036","volume":"101","author":"HH Wang","year":"2018","unstructured":"Wang, H. H., et al. (2018). Ablative hypofractionated radiation therapy enhances non-small cell lung cancer cell killing via preferential stimulation of necroptosis in vitro and in vivo. International Journal of Radiation Oncology, Biology, Physics, 101, 49\u201362. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.036","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10306_CR116","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc1412","volume":"4","author":"H Okada","year":"2004","unstructured":"Okada, H., & Mak, T. W. (2004). Pathways of apoptotic and non-apoptotic death in tumour cells. Nature Reviews. Cancer, 4, 592\u2013603. https:\/\/doi.org\/10.1038\/nrc1412","journal-title":"Nature Reviews. Cancer"},{"key":"10306_CR117","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.surg.2011.09.012","volume":"150","author":"MA Nehs","year":"2011","unstructured":"Nehs, M. A., et al. (2011). Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery, 150, 1032\u20131039. https:\/\/doi.org\/10.1016\/j.surg.2011.09.012","journal-title":"Surgery"},{"key":"10306_CR118","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/10715762.2015.1129534","volume":"50","author":"M Chaurasia","year":"2016","unstructured":"Chaurasia, M., Bhatt, A. N., Das, A., Dwarakanath, B. S., & Sharma, K. (2016). Radiation-induced autophagy: Mechanisms and consequences. Free Radical Research, 50, 273\u2013290. https:\/\/doi.org\/10.3109\/10715762.2015.1129534","journal-title":"Free Radical Research"},{"key":"10306_CR119","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/acschembio.9b00939","volume":"15","author":"LF Ye","year":"2020","unstructured":"Ye, L. F., et al. (2020). Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chemical Biology, 15, 469\u2013484. https:\/\/doi.org\/10.1021\/acschembio.9b00939","journal-title":"ACS Chemical Biology"},{"key":"10306_CR120","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12967-024-05331-3","volume":"22","author":"Y Bao","year":"2024","unstructured":"Bao, Y., et al. (2024). BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity. Journal of Translational Medicine, 22, 519. https:\/\/doi.org\/10.1186\/s12967-024-05331-3","journal-title":"Journal of Translational Medicine"},{"key":"10306_CR121","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41418-019-0393-7","volume":"27","author":"PH Chen","year":"2020","unstructured":"Chen, P. H., et al. (2020). Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death and Differentiation, 27, 1008\u20131022. https:\/\/doi.org\/10.1038\/s41418-019-0393-7","journal-title":"Cell Death and Differentiation"},{"key":"10306_CR122","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","volume":"316","author":"S Matsuoka","year":"2007","unstructured":"Matsuoka, S., et al. (2007). ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 316, 1160\u20131166. https:\/\/doi.org\/10.1126\/science.1140321","journal-title":"Science"},{"key":"10306_CR123","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ijrobp.2020.12.062","volume":"110","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y., Cao, W., Zhou, H., Qian, H., & Wang, H. (2021). CLTRN, regulated by NRF1\/RAN\/DLD protein complex, enhances radiation sensitivity of hepatocellular carcinoma cells through ferroptosis pathway. International Journal of Radiation Oncology, Biology, Physics, 110, 859\u2013871. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.062","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10306_CR124","doi-asserted-by":"publisher","first-page":"37423","DOI":"10.1074\/jbc.M506439200","volume":"280","author":"H Sato","year":"2005","unstructured":"Sato, H., et al. (2005). Redox imbalance in cystine\/glutamate transporter-deficient mice. The Journal of Biological Chemistry, 280, 37423\u201337429. https:\/\/doi.org\/10.1074\/jbc.M506439200","journal-title":"The Journal of Biological Chemistry"},{"key":"10306_CR125","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B., & Conrad, M. (2019). Role of GPX4 in ferroptosis and its pharmacological implication. Free Radical Biology & Medicine, 133, 144\u2013152. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.014","journal-title":"Free Radical Biology & Medicine"},{"key":"10306_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225931","volume":"14","author":"Y Shibata","year":"2019","unstructured":"Shibata, Y., Yasui, H., Higashikawa, K., Miyamoto, N., & Kuge, Y. (2019). Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo. PLoS ONE, 14, Article e0225931. https:\/\/doi.org\/10.1371\/journal.pone.0225931","journal-title":"PLoS ONE"},{"key":"10306_CR127","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3892\/ol.2019.9888","volume":"17","author":"X Pan","year":"2019","unstructured":"Pan, X., et al. (2019). Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis. Oncology Letters, 17, 3001\u20133008. https:\/\/doi.org\/10.3892\/ol.2019.9888","journal-title":"Oncology Letters"},{"key":"10306_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.768248","volume":"9","author":"X Zhang","year":"2021","unstructured":"Zhang, X., et al. (2021). Biomimetic nanomaterials triggered ferroptosis for cancer theranostics. Frontiers in Chemistry, 9, Article 768248. https:\/\/doi.org\/10.3389\/fchem.2021.768248","journal-title":"Frontiers in Chemistry"},{"key":"10306_CR129","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clon.2005.10.002","volume":"18","author":"MV Williams","year":"2006","unstructured":"Williams, M. V., James, N. D., Summers, E. T., Barrett, A., & Ash, D. V. (2006). National survey of radiotherapy fractionation practice in 2003. Clinical Oncology, 18, 3\u201314. https:\/\/doi.org\/10.1016\/j.clon.2005.10.002","journal-title":"Clinical Oncology"},{"key":"10306_CR130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7150\/ijms.3635","volume":"9","author":"R Baskar","year":"2012","unstructured":"Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K. W. (2012). Cancer and radiation therapy: Current advances and future directions. International Journal of Medical Sciences, 9, 193\u2013199. https:\/\/doi.org\/10.7150\/ijms.3635","journal-title":"International Journal of Medical Sciences"},{"key":"10306_CR131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2013.10.032","volume":"356","author":"R Asur","year":"2015","unstructured":"Asur, R., Butterworth, K. T., Penagaricano, J. A., Prise, K. M., & Griffin, R. J. (2015). High dose bystander effects in spatially fractionated radiation therapy. Cancer Letters, 356, 52\u201357. https:\/\/doi.org\/10.1016\/j.canlet.2013.10.032","journal-title":"Cancer Letters"},{"key":"10306_CR132","doi-asserted-by":"publisher","first-page":"737","DOI":"10.7326\/0003-4819-154-11-201106070-00343","volume":"154","author":"K Tipton","year":"2011","unstructured":"Tipton, K., Launders, J. H., Inamdar, R., Miyamoto, C., & Schoelles, K. (2011). Stereotactic body radiation therapy: Scope of the literature. Annals of Internal Medicine, 154, 737\u2013745. https:\/\/doi.org\/10.7326\/0003-4819-154-11-201106070-00343","journal-title":"Annals of Internal Medicine"},{"key":"10306_CR133","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/cco.0b013e328329b716","volume":"21","author":"GE Laramore","year":"2009","unstructured":"Laramore, G. E. (2009). Role of particle radiotherapy in the management of head and neck cancer. Current Opinion in Oncology, 21, 224\u2013231. https:\/\/doi.org\/10.1097\/cco.0b013e328329b716","journal-title":"Current Opinion in Oncology"},{"key":"10306_CR134","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008973","volume":"6","author":"V Favaudon","year":"2014","unstructured":"Favaudon, V., et al. (2014). Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Science Translational Medicine, 6, Article 245ra293. https:\/\/doi.org\/10.1126\/scitranslmed.3008973","journal-title":"Science Translational Medicine"},{"key":"10306_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.644400","volume":"11","author":"B Lin","year":"2021","unstructured":"Lin, B., et al. (2021). FLASH radiotherapy: History and future. Frontiers in Oncology, 11, Article 644400. https:\/\/doi.org\/10.3389\/fonc.2021.644400","journal-title":"Frontiers in Oncology"},{"key":"10306_CR136","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ijrobp.2009.03.030","volume":"76","author":"JA Pe\u00f1agar\u00edcano","year":"2010","unstructured":"Pe\u00f1agar\u00edcano, J. A., Moros, E. G., Ratanatharathorn, V., Yan, Y., & Corry, P. (2010). Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: Initial response rates and toxicity. International Journal of Radiation Oncology, Biology, Physics, 76, 1369\u20131375. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.03.030","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10306_CR137","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.semcancer.2022.03.009","volume":"86","author":"X Niu","year":"2022","unstructured":"Niu, X., Chen, L., Li, Y., Hu, Z., & He, F. (2022). Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC. Seminars in Cancer Biology, 86, 273\u2013285. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.009","journal-title":"Seminars in Cancer Biology"},{"key":"10306_CR138","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W., et al. (2019). CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature, 569, 270\u2013274. https:\/\/doi.org\/10.1038\/s41586-019-1170-y","journal-title":"Nature"},{"key":"10306_CR139","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41419-020-2618-6","volume":"11","author":"DH Kim","year":"2020","unstructured":"Kim, D. H., Kim, W. D., Kim, S. K., Moon, D. H., & Lee, S. J. (2020). TGF-\u03b21-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells. Cell Death & Disease, 11, 406. https:\/\/doi.org\/10.1038\/s41419-020-2618-6","journal-title":"Cell Death & Disease"},{"key":"10306_CR140","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov, A. A., et al. (2020). Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nature Chemical Biology, 16, 278\u2013290. https:\/\/doi.org\/10.1038\/s41589-019-0462-8","journal-title":"Nature Chemical Biology"},{"key":"10306_CR141","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F Veglia","year":"2019","unstructured":"Veglia, F., et al. (2019). Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature, 569, 73\u201378. https:\/\/doi.org\/10.1038\/s41586-019-1118-2","journal-title":"Nature"},{"key":"10306_CR142","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.Can-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., & Ostrand-Rosenberg, S. (2010). Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Research, 70, 68\u201377. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-2587","journal-title":"Cancer Research"},{"key":"10306_CR143","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","volume":"27","author":"H Xu","year":"2021","unstructured":"Xu, H., Ye, D., Ren, M., Zhang, H., & Bi, F. (2021). Ferroptosis in the tumor microenvironment: Perspectives for immunotherapy. Trends in Molecular Medicine, 27, 856\u2013867. https:\/\/doi.org\/10.1016\/j.molmed.2021.06.014","journal-title":"Trends in Molecular Medicine"},{"key":"10306_CR144","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003430","author":"R Demuynck","year":"2021","unstructured":"Demuynck, R., Efimova, I., Naessens, F., & Krysko, D. V. (2021). Immunogenic ferroptosis and where to find it? Journal for Immunotherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-003430","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10306_CR145","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1158\/0008-5472.Can-21-1547","volume":"81","author":"F Fan","year":"2021","unstructured":"Fan, F., et al. (2021). A dual PI3K\/HDAC inhibitor induces immunogenic ferroptosis to potentiate cancer immune checkpoint therapy. Cancer Research, 81, 6233\u20136245. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-1547","journal-title":"Cancer Research"},{"key":"10306_CR146","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019). Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nature Reviews. Cancer, 19, 405\u2013414. https:\/\/doi.org\/10.1038\/s41568-019-0149-1","journal-title":"Nature Reviews. Cancer"},{"key":"10306_CR147","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/cdd.2014.1","volume":"21","author":"VA Tyurin","year":"2014","unstructured":"Tyurin, V. A., et al. (2014). Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic \u2018eat-me\u2019 signals: Cleavage and inhibition of phagocytosis by Lp-PLA2. Cell Death and Differentiation, 21, 825\u2013835. https:\/\/doi.org\/10.1038\/cdd.2014.1","journal-title":"Cell Death and Differentiation"},{"key":"10306_CR148","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","author":"I Efimova","year":"2020","unstructured":"Efimova, I., et al. (2020). Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. Journal for Immunotherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001369","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10306_CR149","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R., & Kroemer, G. (2021). Ferroptosis: Molecular mechanisms and health implications. Cell Research, 31, 107\u2013125. https:\/\/doi.org\/10.1038\/s41422-020-00441-1","journal-title":"Cell Research"},{"key":"10306_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu, C., et al. (2021). The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Reports, 35, Article 109235. https:\/\/doi.org\/10.1016\/j.celrep.2021.109235","journal-title":"Cell Reports"},{"key":"10306_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-021-02669-8","volume":"24","author":"S Li","year":"2022","unstructured":"Li, S., & Huang, Y. (2022). Ferroptosis: An iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy. Clinical and Translational Oncology, 24, 1\u201312. https:\/\/doi.org\/10.1007\/s12094-021-02669-8","journal-title":"Clinical and Translational Oncology"},{"key":"10306_CR152","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/odi.14077","volume":"29","author":"YY Zhao","year":"2023","unstructured":"Zhao, Y. Y., et al. (2023). Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC. Oral Diseases, 29, 933\u2013941. https:\/\/doi.org\/10.1111\/odi.14077","journal-title":"Oral Diseases"},{"key":"10306_CR153","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41467-020-17380-5","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu, B., Choi, B., Li, W., & Kim, D. H. (2020). Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy. Nature Communications, 11, 3637. https:\/\/doi.org\/10.1038\/s41467-020-17380-5","journal-title":"Nature Communications"},{"key":"10306_CR154","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s40425-019-0826-3","volume":"7","author":"VD Turubanova","year":"2019","unstructured":"Turubanova, V. D., et al. (2019). Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. Journal for Immunotherapy of Cancer, 7, 350. https:\/\/doi.org\/10.1186\/s40425-019-0826-3","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10306_CR155","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/s1470-2045(21)00693-8","volume":"23","author":"D Cella","year":"2022","unstructured":"Cella, D., et al. (2022). Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: An open-label, randomised, phase 3 trial. The Lancet Oncology, 23, 292\u2013303. https:\/\/doi.org\/10.1016\/s1470-2045(21)00693-8","journal-title":"The Lancet Oncology"},{"key":"10306_CR156","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa2111380","volume":"386","author":"Y Doki","year":"2022","unstructured":"Doki, Y., et al. (2022). Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. The New England Journal of Medicine, 386, 449\u2013462. https:\/\/doi.org\/10.1056\/NEJMoa2111380","journal-title":"The New England Journal of Medicine"},{"key":"10306_CR157","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s1470-2045(21)00692-6","volume":"23","author":"YK Kang","year":"2022","unstructured":"Kang, Y. K., et al. (2022). Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncology,23, 234\u2013247. https:\/\/doi.org\/10.1016\/s1470-2045(21)00692-6","journal-title":"Lancet Oncology"},{"key":"10306_CR158","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","volume":"18","author":"P Golstein","year":"2018","unstructured":"Golstein, P., & Griffiths, G. M. (2018). An early history of T cell-mediated cytotoxicity. Nature reviews. Immunology,18, 527\u2013535. https:\/\/doi.org\/10.1038\/s41577-018-0009-3","journal-title":"Nature Reviews. Immunology"},{"key":"10306_CR159","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear, A. S., Vonderheide, R. H., & O\u2019Hara, M. H. (2020). Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell,38, 788\u2013802. https:\/\/doi.org\/10.1016\/j.ccell.2020.08.004","journal-title":"Cancer Cell"},{"key":"10306_CR160","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jlb.3ma1220-815rrr","volume":"110","author":"R Kong","year":"2021","unstructured":"Kong, R., Wang, N., Han, W., Bao, W., & Lu, J. (2021). IFN\u03b3-mediated repression of system xc(-) drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. Journal of Leukocyte Biology,110, 301\u2013314. https:\/\/doi.org\/10.1002\/jlb.3ma1220-815rrr","journal-title":"Journal of Leukocyte Biology"},{"key":"10306_CR161","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4049\/jimmunol.1701041","volume":"200","author":"A Sugiura","year":"2018","unstructured":"Sugiura, A., & Rathmell, J. C. (2018). Metabolic barriers to T cell function in tumors. The Journal of Immunology,200, 400\u2013407. https:\/\/doi.org\/10.4049\/jimmunol.1701041","journal-title":"The Journal of Immunology"},{"key":"10306_CR162","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","volume":"26","author":"RJ Kishton","year":"2017","unstructured":"Kishton, R. J., Sukumar, M., & Restifo, N. P. (2017). Metabolic regulation of T cell longevity and function in tumor immunotherapy. Cell Metabolism,26, 94\u2013109. https:\/\/doi.org\/10.1016\/j.cmet.2017.06.016","journal-title":"Cell Metabolism"},{"key":"10306_CR163","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-00478-8","volume":"21","author":"J Muri","year":"2021","unstructured":"Muri, J., & Kopf, M. (2021). Redox regulation of immunometabolism. Nature Reviews Immunology, 21, 363\u2013381. https:\/\/doi.org\/10.1038\/s41577-020-00478-8","journal-title":"Nature Reviews Immunology"},{"key":"10306_CR164","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2326-6066.Cir-20-0384","volume":"9","author":"JM Drijvers","year":"2021","unstructured":"Drijvers, J. M., et al. (2021). Pharmacologic screening identifies metabolic vulnerabilities of CD8(+) T cells. Cancer Immunology Research, 9, 184\u2013199. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0384","journal-title":"Cancer Immunology Research"},{"key":"10306_CR165","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1016\/j.vaccine.2015.05.105","volume":"33","author":"C Vanpouille-Box","year":"2015","unstructured":"Vanpouille-Box, C., Pilones, K. A., Wennerberg, E., Formenti, S. C., & Demaria, S. (2015). In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine, 33, 7415\u20137422. https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.105","journal-title":"Vaccine"},{"key":"10306_CR166","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","volume":"8","author":"KB Pointer","year":"2022","unstructured":"Pointer, K. B., Pitroda, S. P., & Weichselbaum, R. R. (2022). Radiotherapy and immunotherapy: Open questions and future strategies. Trends in Cancer, 8, 9\u201320. https:\/\/doi.org\/10.1016\/j.trecan.2021.10.003","journal-title":"Trends in Cancer"},{"key":"10306_CR167","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijrobp.2020.04.023","volume":"108","author":"JC Jagodinsky","year":"2020","unstructured":"Jagodinsky, J. C., Harari, P. M., & Morris, Z. S. (2020). The promise of combining radiation therapy with immunotherapy. International Journal of Radiation Oncology, Biology, Physics, 108, 6\u201316. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.04.023","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10306_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228877","author":"Q Storozynsky","year":"2020","unstructured":"Storozynsky, Q., & Hitt, M. M. (2020). The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms21228877","journal-title":"International Journal of Molecular Sciences"},{"key":"10306_CR169","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13073-019-0653-7","volume":"11","author":"C Lhuillier","year":"2019","unstructured":"Lhuillier, C., Rudqvist, N. P., Elemento, O., Formenti, S. C., & Demaria, S. (2019). Radiation therapy and anti-tumor immunity: Exposing immunogenic mutations to the immune system. Genome Medicine, 11, 40. https:\/\/doi.org\/10.1186\/s13073-019-0653-7","journal-title":"Genome Medicine"},{"key":"10306_CR170","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/annonc\/mdx790","volume":"29","author":"T Kordbacheh","year":"2018","unstructured":"Kordbacheh, T., Honeychurch, J., Blackhall, F., Faivre-Finn, C., & Illidge, T. (2018). Radiotherapy and anti-PD-1\/PD-L1 combinations in lung cancer: Building better translational research platforms. Annals of Oncology\u202f: Official Journal of the European Society for Medical Oncology, 29, 301\u2013310. https:\/\/doi.org\/10.1093\/annonc\/mdx790","journal-title":"Annals of Oncology : Official Journal of the European Society for Medical Oncology"},{"key":"10306_CR171","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1007\/s00262-023-03544-x","volume":"72","author":"Q Huang","year":"2023","unstructured":"Huang, Q., et al. (2023). Carbon ion radiotherapy combined with immunotherapy: Synergistic anti-tumor efficacy and preliminary investigation of ferroptosis. Cancer Immunology, Immunotherapy, 72, 4077\u20134088. https:\/\/doi.org\/10.1007\/s00262-023-03544-x","journal-title":"Cancer Immunology, Immunotherapy"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10306-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:09:29Z","timestamp":1765375769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10306-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":171,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10306"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10306-x","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}